They're exploring its use for groundbreaking treatments for cancer and autoimmune disease, as well as for gene-editing ...

Q3 2025 Earnings Call Transcript October 29, 2025 BridgeBio Pharma, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Beijing Tsingke Biotech Co., Ltd., a pioneer in molecular manufacturing, showcased its next-generation integrated platforms at the 2025 Festival of Biologics in Basel. Over 2,000 biotech experts from ...

Net Loss -- Net loss was $13.6 million for the third quarter of 2025, compared to $16.4 million in Q3 2024. Ending Cash, Cash ...

The global cancer-therapy landscape is undergoing a rapid evolution toward precision drug-delivery systems designed to boost efficacy, limit toxicity and elevate patient outcomes. Conventional oral ...

The Inflammatory Diseases Market, valued at USD 22.5 billion in 2025, is projected to reach USD 34.9 billion by 2035, ...

Genomic research has found the endangered hoiho is made up of three distinct subspecies, a discovery that may help guard ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Traditional breeding and genetic modification methods have struggled to keep pace with the rapid evolution of plant viruses. CRISPR/Cas systems, originally derived from bacterial immune responses, ...

According to the HSRC report, Gross Domestic Expenditure on Research and Development (GERD) stood at R43.413 billion in ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...